☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Biotheus
Biotheus Reports Collaboration Expansion with Hansoh Pharma to Develop EGFR/cMET Bispecific Antibody-Drug Conjugates
March 15, 2024
Biotheus and Bitterroot Bio Join Forces for the Development of Bispecific Proteins in Cardio-Immunology
February 27, 2024
Biotheus Collaborates with BioNTech for the Development and Commercialization of PM8002 to Treat Multiple Solid Tumor Indications
November 7, 2023
Biotheus Entered into a Research Collaboration and License Agreement with BioNTech to Discover Novel Therapies for Cancer
July 20, 2023
Biotheus Entered into a License and Collaboration Agreement with Hansoh Pharma for PM1080
November 15, 2022
PharmaShots Weekly Snapshot (August 19 - 23, 2019)
August 26, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.